期刊文献+

富硒羊肚菌多糖的制备及其体外抗肿瘤活性探究

Preparation of Selenium-enriched Morchella Polysaccharide and Its Antitumor Activity in Vitro
下载PDF
导出
摘要 本研究旨在优化提取和纯化富硒羊肚菌多糖(Se-MPS),并评估其抗肿瘤活性及其机制。采用单因素和响应面优化法,对富硒羊肚菌粗多糖的提取工艺进行优化。通过柱层析法对粗多糖进行纯化,并对其化学组成进行分析。使用HepG2细胞进行CCK-8试验、集落形成试验、划痕试验和Transwell试验来评价Se-MPS的抗肿瘤活性。采用RT-qPCR法、Western blot法和免疫荧光法评价Se-MPS的潜在抗肿瘤机制。单因素和响应面试验结果显示,富硒羊肚菌粗多糖提取的最佳工艺参数为:提取时间2.5 h、液料比45:1(mL/g)、提取温度82℃,得率为7.95%。纯化后,Se-MPS的总糖含量达到95.86%,硒含量高达76.07±0.32 mg/g。此外,Se-MPS显著降低了HepG2细胞的集落形成效率、细胞迁移率和侵袭细胞数目(P<0.05)。同时,Se-MPS抑制了PI3K/Akt通路传导,下调了葡萄糖转运蛋白2(GLUT2)的mRNA表达,并降低了细胞的葡萄糖摄取量。研究结果表明,通过对提取时间、液料比及提取温度的优化,可改善富硒羊肚菌粗多糖得率。此外,通过调控PI3K/Akt通路,富硒羊肚菌多糖可发挥出较强的抗肿瘤活性。这项研究为富硒羊肚菌多糖的抗肿瘤活性提供了证据,并为相关功能性食品的开发提供了参考。 This study aimed to optimize the extraction and purification processes for selenium-enriched Morchella esculenta(L.)Pers.(also known as Morchella)polysaccharides(Se-MPS)and to evaluate their anti-tumor activities and mechanisms.The extraction process was optimized using single-factor and response surface methodology.The crude polysaccharides were purified through column chromatography and their chemical composition was analyzed.The anti-tumor activity of Se-MPS was evaluated using HepG2 cells through a series of assays,including CCK-8,colony formation,scratching,and Transwell assays.The potential anti-tumor mechanisms of Se-MPS were assessed using RT-qPCR,Western blot,and immunofluorescence methods.Experimental results from single-factor and response surface methodology revealed that the optimal extraction conditions for selenium-enriched Morchella crude polysaccharides were:An extraction time of 2.5 h,a liquid-to-material ratio of 45:1(mL/g),and an extraction temperature of 82℃,yielding a crude polysaccharides yield of 7.95%.After purification,the total sugar content of Se-MPS reached 95.86%,with a selenium concentration of 76.07±0.32 mg/g.Furthermore,Se-MPS significantly reduced colony formation efficiency,cell migration rate,and the number of invasive cells in HepG2 cells(P<0.05).Meanwhile,Se-MPS inhibited the PI3K/Akt signaling pathway,down-regulated mRNA expression of glucose transporter 2(GLUT2),and reduced glucose uptake in cells.The results indicated that optimizing extraction time,liquid-to-material ratio,and extraction temperature could improve the yield of seleniumenriched Morchella crude polysaccharides.Additionally,Se-MPS exhibited strong anti-tumor activity by regulating the PI3K/Akt pathway.This study provides evidence of the anti-tumor activities of Se-MPS and offers insights for the development of related functional foods.
作者 李贝贝 王慧琴 孙仪征 LI Beibei;WANG Huiqin;SUN Yizheng(Zhengzhou Shuqing Medical College,Zhengzhou 450064,China)
出处 《食品工业科技》 CAS 北大核心 2024年第15期213-222,共10页 Science and Technology of Food Industry
基金 河南省重点研发专项(221111112300) 郑州澍青医学高等专科学校骨干教师培养计划(2024ssgg04) 郑州澍青医学高等专科学校2024年教师教学创新团队培养计划(2024jxcxtd01)。
关键词 羊肚菌多糖 化学组成 响应面优化 抗肿瘤活性 selenium Morchella polysaccharide chemical composition response surface optimization anti-tumor activity
  • 相关文献

参考文献2

二级参考文献35

  • 1王玮,蔡建辉,马毓梅,徐素欣,郝桂敏,李晓冬.GLUT4在多囊卵巢综合征大鼠子宫内膜中的表达及意义[J].中国病理生理杂志,2007,23(3):587-590. 被引量:9
  • 2Zhang S, Ma Y, Jiang J, et al. Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells[J]. Oncol Lett, 2014, 7(5):1375-1380.
  • 3Kong R, Jia G, Cheng ZX, et al. Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5[J]. PLoS One, 2012, 7(5):e37222.
  • 4Zhou HJ, Zhang JL, Li A, et al. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro[J].Cancer Chemother Pharm, 2010, 66(1):21-29.
  • 5Wang SJ, Sun B, Cheng ZX, et al. Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway[J]. Cancer Chemother Pharm, 2011, 68(6):1421-1430.
  • 6Zhao YG, Wang Y, Guo Z, et al. Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway[J]. J Immunol, 2012, 189(9):4417-4425.
  • 7Ariffin AB, Forde PF, Jahangeer S, et al. Releasing pressure in tumors:what do we know so far and where do we go from here? A review[J]. Cancer Res, 2014, 74(10):2655-2662.
  • 8Li X, Luo H, Paul SC, et al. Downregulation of the expression of GLUT1 plays a role in apoptosis induced by sodium butyrate in HT-29 cell line[J]. Int J Mol Sci, 2006, 7(3):59-70.
  • 9Laplante M, Sabatini DM. mTOR signaling in growth control and disease[J]. Cell, 2012, 149(2):274-293.
  • 10Cornu M, Albert V, Hall MN. mTOR in aging, metabolism, and cancer[J]. Curr Opin Genet Dev, 2013, 23(3):53-62.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部